华北制药 (600812)

North China Pharmaceutical Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 171573.04
  • Circulating A-Shares(W): 171573.04
  • Earnings Per Share(RMB): 0.0920
  • Net Assets Per Share(RMB): 3.2087
  • Operating Revenue(W RMB): 748482.86
  • Total Profit(W RMB): 28721.56
  • **Net Profit Attributable to Parent(W RMB) **: 15850.40
  • Net Profit Growth Rate(%): 54.69
  • Weighted Return on Equity(%): 2.8980
  • Operating Cash Flow Per Share(RMB): 0.3860
  • Undistributed Profit Per Share(RMB): -0.2466
  • Capital Reserve Per Share(RMB): 2.2555

2. Main Business

The main business covers:

  • Research, development, production and sales of pharmaceutical products

3. Company Basic Information

  • Company Name: North China Pharmaceutical Co., Ltd.
  • Listing Date: 1994-01-14
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 388 Heping East Road, Shijiazhuang City, Hebei Province
  • Website: https://www.ncpc.com/
  • Company Profile: The company's predecessor was North China Pharmaceutical Factory. In August 1992, it began restructuring into a joint-stock company, converting the original company's net assets into 491.7791 million state-owned shares. After the initial public offering from August 1992 to October 1993, the total number of shares at the time of listing was 660 million shares; 21.608598 million internal employee shares were listed for trading on September 22, 1994.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Jizhong Energy Co., Ltd. General Legal Person 41308.05 24.08
2 North China Pharmaceutical Group Co., Ltd. General Legal Person 34147.16 19.90
3 Jizhong Energy Group Co., Ltd. General Legal Person 18914.67 11.02
4 Central Huijin Asset Management Co., Ltd. Special Legal Person 5491.66 3.20
5 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2005.31 1.17
6 Caida Securities Co., Ltd. Securities Company 1320.00 0.77
7 Southern China Securities 1000 ETF Fund 784.47 0.46
8 ChinaAMC China Securities 1000 ETF Fund 466.25 0.27

5. Concept Sectors

  • Biological Vaccines
  • Xiongan New Area
  • Gene Concept
  • Vitamins
  • Generic Drugs
  • Fertilizer Concept
  • Hepatitis Concept
  • Innovative Drugs
  • Synthetic Biology
  • DeepSeek

Remarks

  • Data update date: 2025-10-24
  • Data source: Public market information